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Aim: To determine the frequency with which the CCR5-Δ32 mutant allele caused resistance to HIV, which is main agent of AIDS in all
geographic regions of Turkey.
Materials and methods: Randomly selected human blood samples from 400 healthy individuals were collected. The polymerase chain
reaction method was used to determine the CCR5-Δ32 polymorphism and samples were screened using 2 primers.
Results: The frequency of wild alleles was found to be 0.9738 and the frequency of mutant alleles was found to be 0.0262. The highest
frequency of the CCR5-Δ32 allele was found to be 0.0726 in the Central Anatolia region. The lowest frequency of the CCR5-Δ32 allele
was found to be 0.0093 in the Southeast Anatolia and the Mediterranean regions. The mutant allele was not observed in any individuals
from the Marmara region. Homozygosity was not observed in terms of this mutant allele in the individuals studied.
Conclusion: According to the data obtained from this study, the frequency of CCR5-Δ32, except for in the Marmara region, showed
parallelism with a decrease consistent with a north-south direction across the world. This study was conducted to determine the
frequency of the CCR5-Δ32 allele, which is important for the evaluation of samples that are representative of all the geographic regions
of Turkey.
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1. Introduction
Acquired immune deficiency syndrome (AIDS) emerges
with the involvement of the immune system by a
virus named human immunodeficiency virus (HIV).
Intracellular replication of this virus harms the cell.
HIV mostly infects T lymphocytes known as CD4+ or
T-helpers. Some individuals have a mutant chemokine
receptor gene that provides resistance or partial immunity
against HIV. Chemokines include 70–90 amino acids
weighing 8–10 kDa, which activate different cell types and
are interrelated with them. Chemokine receptors that have
20%–70% common amino acid sequences are divided into
3 groups [C, CC (b), CXC (a)] according to the amount
and location of cysteine in their structure. Of them, the
chemokine 5 receptor (CCR5) has a 352 amino acid
sequence, its molecular mass is 40,600 Da, and it is located
on the third chromosome (1–5). The relationship of CCR5
and the chemokine 2 receptor (CCR2) and HIV has been
put forward in studies.
* Correspondence: azhar2498@yahoo.com
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The mutant CCR5 allele is related to HIV resistance in
human genomes. A 32-bp deletion in the human CCR5
gene leads to this resistance (1,2). HIV should attack the
CCR5 receptor in order to infect CD4+ T cells. Individuals
who have this mutation either do not have the CCR5
receptor or have less than the mean number of CCR5
receptors. Presence of the CCR5-Δ32 allele provides
very strong protection against the retransfer of HIV in
homozygous individuals. On the other hand, the typical
course of the disease has been reported to be delayed for
about 2 years in heterozygous individuals (6,7).
A population that has both the highest Δ32 frequency
and the highest HIV infection together is not known
today. Many populations in North Europe have Δ32 allele
frequency in the ratio of 0.1–0.2. Meanwhile, the Δ32
frequency is low and almost nil in African populations in
which AIDS is common. The highest Δ32 allele frequency
has been reported as 21% as the result of many population
screenings (8–10).
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In this study, it was aimed to determine CCR5-Δ32
allele frequency, which has great importance for resistance
against HIV, by taking all geographical regions of Turkey
into consideration.
2. Materials and methods
2.1. Collection of samples and DNA isolation
We ensured that there were blood samples representing
all of the geographical regions of Turkey. Blood samples
were obtained from a total of 400 healthy individuals (259
females, 141 males; Table 1). The blood samples were
taken from volunteer participants and were obtained in
accordance with the requirements of informed consent,
and 2 cm3 of each blood sample was put into tubes
containing EDTA and stored at 4 °C.
DNA isolation from the blood was performed
according to QIAamp DNA Mini Kit (QIAGEN) protocol.
2.2. Optimization of polymerase chain reaction (PCR)
conditions
Molecular genetic analysis of individuals was done with
the PCR method. Two primers that gave the best results in
trials were used for the analysis of samples (Table 2).
A PCR reaction mixture was prepared in a total
volume of 15 µL in such a way as to include 50–100 ng
DNA sample, 1X PCR buffer ((NH4)SO4, Fermentas), 2
mM MgCl2, 200 µM dNTP, 3 pmol primer, and 0.5 U Taq
DNA polymerase. PCR conditions for the SP4.760 primer
were realized in a total of 35 cycles as 40 s at 94 °C for
denaturation after a predenaturation procedure for 4 min
at 94 °C, 45 s at 58 °C for primer bonding, and 1 min at
72 °C for elongation. Afterwards, it was kept at 72 °C for
10 min in order to complete the elongation procedure.
Samples that completed the PCR procedure were kept
at 4 °C until the elution procedure. These conditions
for the AB primer used in the study were realized in a
total of 35 cycles as 30 s at 94 °C for denaturation after a
predenaturation procedure for 4 min at 94 °C, 40 s at 58
Table 1. Distribution of participants according to number and
regions.
Regions

Number of participants

Black Sea region

61

Marmara region

58

Aegean region

57

Mediterranean region

54

Southeast Anatolia region

54

East Anatolia region

54

Central Anatolia region

62

TOTAL

400

°C for primer bonding, and 40 s at 72 °C for elongation.
Afterwards, it was kept at 72 °C for 10 min in order to
complete the elongation procedure.
2.3. Agarose gel electrophoresis
PCR products to which 6X loading dye was added were
eluted for approximately 2 h with 1.7% agarose gel so as to
be 5 V/cm. DNA band profiles obtained with a gel imaging
system were transferred to a computer environment and
photographed.
2.4. Statistical analysis
Homozygous individuals were taken as ‘AA’ and
heterozygous individuals were taken as ‘AB’ for the data
analysis. Chi-square analysis was used for the assessment
of genotype and allele frequencies. Expected and observed
frequencies of genotypes were calculated. The expected
heterozygosity value was assessed using the PopGene
(version 1.31) computer program (11,12).
3. Results
CCR5-Δ32 allele frequency as related to resistance against
HIV was determined with the analysis of blood samples
obtained from a total of 400 individuals. Blood samples
were collected in such a way as to represent all provinces
included in the region. Twenty-one of the individuals
who were screened with 2 primers were found to be
heterozygous in terms of the CCR5-Δ32 allele (CCR5/
CCR5-Δ32). No homozygous individuals (CCR5-Δ32/
CCR5-Δ32) were determined in the study. A single band
measuring 241 bp was detected in individuals with the
CCR5/CCR5 genotype and 2 bands measuring 209 and
241 bp were determined in individuals with the CCR5/
CCR5-Δ32 genotype as a result of screening samples with
the SP4.760 primer (Figure 1). A single band measuring
225 bp was detected in individuals with the CCR5/CCR5
genotype and 2 bands measuring 193 and 225 bp were
determined in individuals with the CCR5/CCR5-A32
genotype as a result of screening with the AB primer
(Figure 2).
While the wild allele frequency was found to be 0.9738
for all individuals, the mutant allele frequency was 0.0262.
In the statistical analysis done according to geographical
regions, while wild allele frequency was found to be 0.9590
for the population representing the Black Sea region,
Table 2. Names and sequences of primers used in the study.
Names of primers
SP4.760
AB

Sequences of primers (5’-3’)
CCTCATTACACCTGCAGCTCT
CACAGCCCTGTGCTTCTTCTT
ACCAGATCTCAAAAAGAAGGTCT
CATGATGGTGAAGATAAG CCTCACA
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241 bp
241 bp

209 bp
209 bp

500 bp
400 bp 500 bp
300 bp 400 bp
200 bp 300 bp
200 bp
100 bp 100 bp

Figure 1. DNA band profiles obtained with SP4.760 primer [M: 100-bp DNA
determinant; 7, 8, 14: heterozygous individuals; 1, 2, 3, 4, 5, 6, 9, 10, 11, 12, 13, 15, 16,
17, 18, 19, 20: wild type (CCR5/CCR5)].

225 bp

500 bp
400 bp
300 bp
200 bp

193 bp

100 bp

Figure 2. DNA band profiles obtained with AB primer [(M: 100-bp DNA determinant;
7, 8, 14: heterozygous individuals; 1, 2, 3, 4, 5, 6, 9, 10, 11, 12, 13, 15, 16, 17, 18, 19, 20:
wild type (CCR5/CCR5)].

mutant allele frequency was 0.0410. No heterozygous
individuals who had the mutant genotype were detected
in the population representing the Marmara region.
While wild allele frequency was found to be 0.9825 for
the population representing the Aegean region, mutant
allele frequency was 0.0175. While wild allele frequency
was found to be 0.9274 for the population representing
the Central Anatolia region, mutant allele frequency was
0.0726. While wild allele frequency was found to be 0.9722
for the East Anatolia region, mutant allele frequency
was 0.0278. While wild allele frequency was found to be
0.9907 for the population representing the Mediterranean
region, mutant allele frequency was 0.0093. While wild
allele frequency was found to be 0.9907 for the Southeast
Anatolia region, mutant allele frequency was 0.0093. The
Central Anatolia region was found to have the population
with the highest heterozygous percentage among the
analyzed populations. Heterozygous statistical values
for all individuals are given in Table 3. In addition, the
chi-square value used in Hardy–Weinberg equilibrium
analysis was estimated to be 0.276506, the freedom degree
to be 1, and probability (P) to be 0.599000 (Table 4).
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4. Discussion
In many studies conducted at the beginning of the 1990s, it
was reported that some people were not infected although
they had been repeatedly exposed to HIV, and some infected
people lived longer than expected (13). Recognition of the
molecular mechanism of this resistance was achieved with
the definition of co-receptor molecules that enable the
entrance of HIV into macrophages and T cells (14,15).
In previous studies, it was shown that resistance against
HIV was provided or the course of the disease was slowed
down in the presence of allele variants in CCR5 and CCR2
(1,2). Research about the worldwide distribution models
of variants was conducted after these studies. In a study
by Martinson et al., it was reported that CCR5-Δ32 allele
frequency was quite high in North European populations,
while this frequency reduced towards the South and East
and almost none is seen in Africa, Oceania, the Middle
East, or West Asia (8). In a large-scale sample composed of
a total of 8842 noninfected individuals obtained from 40
different white populations including Europe, the Middle
East, and North Africa, Lucotte et al. reported that Δ32
allele frequency significantly reduced from north to south
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Table 3. Heterozygosity statistical results for two locus of the population composed of 400 individuals.
Locus

Sample size

Observed
homozygosity

Observed
Expected
Expected
Nei**
heterozygosity homozygosity* heterozygosity*

The average
heterozygosity

SP4.70

800

0.9475

0.0525

0.9488

0.0512

0.0511

0.0511

AB

800

0.9475

0.0525

0.9488

0.0512

0.0511

0.0511

Ort.
Standard
deviation

800

0.9475

0.0525

0.9488

0.0512

0.0511

0.0511

0.0000

0.0000

0.0000

0.0000

0.0000

0.0000

0.0000

*: Expected homozygous and heterozygous data were obtained using Levene’s method (11).
**: Expected heterozygosity value of Nei (12).
Table 4. Chi-square and P values used for Hardy–Weinberg equilibrium analysis of 400 individuals.
Genotype

Observed number of
individuals (O)

Expected number of
individuals (E)

(O – E)² / E

2.O.Ln(O / E)

(A, A)

379

379.2628

0.0002

–0.5255

(A, B)

21

20.4743

0.0135

1.0647

(B, B)

0

0.2628

0.2628

0.0000

(from North Europe to North Africa). It was reported
that the frequency of the Δ32 allele was 13.4% among the
populations of Sweden, Norway, Denmark, Finland, and
Iceland, and this value was quite higher than mean Δ32
values; the lowest frequency was reported from the more
southern countries of Morocco, Tunisia, Syria, and Iran
(16).
Despite the presence of population studies in Turkey,
these studies were limited to certain regions or certain
populations. According to a study in 2004, a randomly
selected Turkish population was analyzed and the mutant
allele frequency was detected to be 2.18%. No CCR5-Δ32
homozygous individuals were detected in that study (17).
In the present study, the mutant allele frequency was
found to be a mean of 1.95% for all regions and no mutant
homozygous individuals were encountered. However, the
Central Anatolia region was different from others with a
mutant allele frequency of 7.26%. This result is parallel
with the mutant allele frequency (6.3%) found in the study
of Libert et al., which included 18 European countries
and 104 individuals from Ankara, the only province from
Turkey that took part in the study (18). Similarly, in a study
conducted by Güneş et al. (3), healthy individuals living
in the coastal region of the Middle Black Sea region were
analyzed and the mutant Δ32 allele frequency was reported
to be 5.2%. In the present study, a similar frequency value
(4.1%) was found for the Black Sea region.
When the chi-square and probability values
calculated using the PopGene program for all individuals
are taken into consideration (at P < 0.05 significance level),

the H0 hypothesis is acceptable; the population is at Hardy–
Weinberg equilibrium. This result is parallel with that of
Güneş et al. (3).
The present study is the first conducted with subjects
selected from all geographical regions of Turkey. A total of
400 individuals with 54–61 from each region were analyzed
for the CCR5- Δ32 allele. The CCR5-Δ32 mutant allele
frequency was found to be 0.0262 for all individuals. This
frequency value is parallel with the values of Christodoulou
et al. regarding the Cretan population in Greece (0.028) and
Battiloro et al. regarding the Italian Sardinian population
(0.021) (19,20). In this study, a difference was observed in
the distribution of CCR5-Δ32 allele frequency according to
regions. Central Anatolia is the region in which this allele is
represented with the highest frequency (0.0726). Frequency
values obtained for the Mediterranean region and Southeast
Anatolia region were found to be equal (0.0093). The Δ32
allele was not encountered in the analysis of the sample
selected for the Marmara region. It is thought that a
reevaluation of the Marmara region with higher numbers of
samples and screened primers would provide better results.
In this study, all geographical regions of Turkey were
evaluated for the first time in terms of this allele. Data
showed that frequency of that allele was consistent with its
reduction from north to south worldwide, except for in the
Marmara region.
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